📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Protez Pharmaceuticals

1.1 - Company Overview

Protez Pharmaceuticals Logo

Protez Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of differentiated intravenous and oral small molecule antibiotics for difficult-to-treat hospital-based infections, addressing bacterial resistant and chronic or recurrent infections; discovers, develops, and commercializes antibiotic therapies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Protez Pharmaceuticals

Okairos Logo

Okairos

HQ: Switzerland Website
  • Description: Provider of biopharmaceutical discovery and development of genetic T-cell vaccines, including for hepatitis C virus, and health and allied services. Based in Basel, Switzerland, with operations in Rome and Naples, Italy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okairos company profile →
Adrenomed Logo

Adrenomed

HQ: Germany Website
  • Description: Provider of clinical-stage biopharmaceutical development focused on rescuing vascular integrity to save critically ill patients with limited treatment options, including the lead product candidate Adrecizumab, a first-in-class monoclonal antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adrenomed company profile →
Eurocine Vaccines Logo

Eurocine Vaccines

HQ: United States Website
  • Description: Provider of nasal flu vaccines for children and the elderly, managing preclinical and clinical development, scalability into manufacturing, business development, and funding. Offers Endocine, a nasal vaccine adjuvant used in clinical trials showing safety and tolerability in over 400 human subjects; an HSV-2 therapeutic vaccine candidate; and vaccine development services from conceptualization to commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eurocine Vaccines company profile →
Utility Therapeutics Logo

Utility Therapeutics

HQ: United Kingdom Website
  • Description: Provider of antibiotics focused on combating multi-drug resistant bacterial infections in the US, including PIVYA (pivmecillinam, oral) for UTIs with a unique mode of action addressing resistance, and mecillinam (IV) targeting penicillin binding protein-2 in gram-negative bacteria and stable against β-lactamase hydrolysis, plus a development program working with the FDA to make PIVYA tablets available for uncomplicated UTIs in the US.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Utility Therapeutics company profile →
GlycoVaxyn Logo

GlycoVaxyn

HQ: Switzerland Website
  • Description: Provider of biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology, developing and manufacturing immunogenic glycoprotein conjugate vaccines for a range of bacterial diseases, including pneumococcal and nosocomial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GlycoVaxyn company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Protez Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Protez Pharmaceuticals

2.2 - Growth funds investing in similar companies to Protez Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Protez Pharmaceuticals

4.2 - Public trading comparable groups for Protez Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Protez Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Protez Pharmaceuticals

What does Protez Pharmaceuticals do?

Protez Pharmaceuticals is a provider of differentiated intravenous and oral small molecule antibiotics for difficult-to-treat hospital-based infections, addressing bacterial resistant and chronic or recurrent infections; discovers, develops, and commercializes antibiotic therapies.

Who are Protez Pharmaceuticals's competitors?

Protez Pharmaceuticals's competitors and similar companies include Okairos, Adrenomed, Eurocine Vaccines, Utility Therapeutics, and GlycoVaxyn.

Where is Protez Pharmaceuticals headquartered?

Protez Pharmaceuticals is headquartered in United States.

How many employees does Protez Pharmaceuticals have?

Protez Pharmaceuticals has 1,000 employees 🔒.

When was Protez Pharmaceuticals founded?

Protez Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Protez Pharmaceuticals in?

Protez Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Protez Pharmaceuticals

Who are the top strategic acquirers in Protez Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Protez Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Protez Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Protez Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Protez Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Protez Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Protez Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Protez Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Protez Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Protez Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Protez Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Protez Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Protez Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Protez Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Protez Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Protez Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Protez Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Protez Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Protez Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Protez Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Protez Pharmaceuticals